Family Medicine · New York, NY
NPI
1144334699
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2256 2nd Ave Fl 2
New York, NY, 10029
Phone (212) 758-7777
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
348 services
Medicare patients, 2024
44
Average age 71
Drug cost, 2024
$3.0M
13,986 prescriptions
Company payments, 2025
$1,250
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Leonid Bukhman was code 99213 (office e&m - established), 132 times for 42 patients. In total Leonid Bukhman billed 348 services in 24 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 132 | 42 | $78.08 | $10K |
| 36415 Venipuncture Blood Collection | Office | 32 | 23 | $8.65 | $277 |
| 93931 Duplex Scan - Extremity Arteries | Office | 27 | 26 | $89.48 | $2,416 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 27 | 26 | $161.68 | $4,365 |
| 93888 Ultrasound - Nonspecific | Office | 17 | 17 | $114.88 | $1,953 |
| 81002 Clinical Chemistry | Office | 17 | 16 | $3.41 | $57.97 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 12 | 12 | $144.87 | $1,738 |
| 93306 Echocardiography (TTE/TEE) | Office | 11 | 11 | $162.10 | $1,783 |
By year: 2022 $40K for 401 services; 2023 $27K for 317 services; 2024 $29K for 348 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 32 | 23 | $8.65 | $277 |
| 81002 Clinical Chemistry | 17 | 16 | $3.41 | $57.97 |
Medicare prescription drug claims, 2024
In 2024, the drug Leonid Bukhman prescribed most often to Medicare patients was Atorvastatin Calcium, with 611 prescriptions and refills. In total Leonid Bukhman wrote 13,986 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 611 | 1,514 | 179 | $6,186 |
| Diclofenac Sodium Generic | 514 | 990 | 134 | $259K |
| Omeprazole Generic | 466 | 1,125 | 140 | $5,697 |
| Amlodipine Besylate Generic | 418 | 1,151 | 124 | $2,216 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 397 | 734 | 112 | $23K |
| Metformin Hcl Generic | 361 | 878 | 99 | $1,641 |
| Gabapentin Generic | 352 | 803 | 101 | $4,624 |
| Losartan Potassium Generic | 343 | 848 | 100 | $3,064 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 287 | 596 | 76 | $400 |
| Fluticasone Propionate Generic | 280 | 552 | 84 | $3,641 |
| Hydrochlorothiazide Generic | 279 | 755 | 87 | $895 |
| Simvastatin Generic | 251 | 694 | 74 | $1,655 |
| Alendronate Sodium Generic | 247 | 649 | 82 | $1,659 |
| Metoprolol Succinate Generic | 244 | 648 | 63 | $3,325 |
| Meclizine Hcl Generic | 236 | 522 | 71 | $3,323 |
Brand drugs: 2,773 claims; generic drugs: 10,656 claims; opioid claims: 108.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Leonid Bukhman $1,250 ($1,250 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $308.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $308 |
| Amgen Inc. AMGN | 6 | $226 |
| Novo Nordisk Inc NVO | 3 | $184 |
| Genzyme Corporation SNY | 4 | $148 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $130 |
| GlaxoSmithKline, LLC. GSK | 3 | $64.3 |
| Lilly USA, LLC LLY | 3 | $57.35 |
| Scilex Pharmaceuticals Inc. | 2 | $45.49 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $37.96 |
| Kowa Pharmaceuticals America, Inc. | 1 | $27.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.